| | | | | | What you need to know about the coronavirus today | Global daily deaths cross record The number of reported global daily deaths from the coronavirus stood at 10,816, according to a Reuters tally, the highest single-day death count. The previous record of global daily deaths was 10,733, registered on November 4, according to the Reuters tally.
The United States, the worst-affected country worldwide, has reported about 11.38 million infections and 248,574 deaths since the pandemic started.
Pfizer said final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days.
COVID-19 infections are still rising in 70 countries. Track daily infections and deaths data for 240 countries and territories around the world. | | | | | | U.S. medical leaders rebuke Trump The U.S. medical establishment urged President Donald Trump to share critical COVID-19 data with President-elect Joe Biden’s team to avoid needless, deadly lags in tackling the pandemic. The extraordinary rebuke came in an open letter from three leading healthcare organizations as state and local governments scrambled to fight the virus in the absence of a coordinated national strategy.
Sinovac’s vaccine induces quick immune response Sinovac Biotech’s experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed. While the early to mid-stage trials were not designed to assess the efficacy of CoronaVac, researchers said it could provide sufficient protection, based on their experience with other vaccines and data from preclinical studies with macaques.
‘Highly contagious’ outbreak in South Australia South Australia declared a six-day lockdown to stamp out what the state premier described as a highly contagious outbreak of the coronavirus disease that officials linked to a returned traveler from Britain. Most businesses will close, except for some food outlets, and people will be largely confined to their homes as the state tries to avoid a more severe breakout like the one that all but shuttered neighboring Victoria for more than 100 days.
Infected Russian governor sparks anger A Russian regional governor’s decision to be treated for COVID-19 in a private Moscow clinic rather than in his own region drew public criticism, as Russia reported a new record daily high of 456 coronavirus-related deaths. The disparity in healthcare provision between the Russian capital and other regions is something that the Kremlin recognizes. It has pumped extra resources into the regions, some of which have complained of staff, equipment and bed shortages, in an effort to narrow that gap.
| | | | From Breakingviews - Corona Capital: Cycling, Unilever, Video games. Catch up with the latest pandemic-related financial insights, from the United Kingdom’s bicycle boom to Unilever’s plant-based ambitions, in the latest edition of Corona Capital. | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | | | | | | | | | Top Stories on Reuters TV | | | | | | | |
没有评论:
发表评论